Stephen G. Ellis, MD, is the Section Head of Invasive/Interventional Cardiology in the Robert and Suzanne Tomsich Department of Cardiovascular Medicine at the Sydell and Arnold Miller Family Heart & Vascular Institute. He also is co-director and co-founder of the Cardiovascular Genebank. His principal clinical interests are complex coronary interventions, novel treatments for inoperable patients and studies to better understand the basis of disease.

Board-certified in internal medicine cardiology and interventional cardiology, Dr. Ellis is a member of the American Heart Association's Scientific Council on Arteriosclerosis and Scientific Council on Clinical Cardiology, the Society for Cardiac Angiography and Interventions and the American College of Cardiology.

He also serves on the editorial boards for numerous publications, including the American Journal of Cardiology, the Journal of Interventional Cardiology, Circulation and the American Heart Journal. Dr. Ellis has authored and co-authored more than 700 papers on interventional cardiology and cardiovascular disease for scientific journals including the New England Journal of Medicine, Circulation, Journal of the American College of Cardiology and American Journal of Cardiology.

He has also served as the principal investigator for numerous national and international clinical studies that focus on intervention, including the RESCUE I trial, GUSTO IIb PTCA study, ERASER study, the GUARD trial, TAXUS IV and V trials and the FINESSE trial.

A graduate of the University of California (at Los Angeles) Medical School, Dr. Ellis completed his internship and residency at Cedars-Sinai Medical Center in Los Angeles and his fellowships at the Brigham and Women's Hospital (Cardiology) in Boston, Stanford University (Cardiology) in Stanford, Calif., and Emory University (Angioplasty) in Atlanta.

A graduate of the University of California (at Los Angeles) Medical School, Dr. Ellis completed his internship and residency at Cedars-Sinai Medical Center in Los Angeles and his fellowships at the Brigham and Women's Hospital (Cardiology) in Boston, Stanford University (Cardiology) in Stanford, Calif., and Emory University (Angioplasty) in Atlanta.

Fellowship - Emory University Hospital

Angioplasty
Decatur, GA USA
1986

Fellowship - Stanford University Hospital

Cardiology
Stanford, CA USA
1985

Fellowship - Brigham & Women's Hospital

Cardiology
Boston, MA USA
1982

Residency - Cedars-Sinai Medical Center

Internal Medicine
Los Angeles, CA USA
1981

Internship - Cedars-Sinai Medical Center

Internal Medicine
Los Angeles, CA USA
1979

Medical School - University of California-Los Angeles School of Medicine

Los Angeles, CA USA
1978

Undergraduate - Stanford University

Palo Alto, CA USA
1973

• Internal Medicine
• Internal Medicine- Cardiovascular Disease
• Internal Medicine- Interventional Cardiology

• Regent’s Scholar, University of California, 1973-1976, 1978
• Distinguished Teaching Awards, 1992, 1996, 2003
• The Best doctors in America, Cleveland Clinic,  1993-present
• The Best Doctors in Cleveland, 2001-present
• NIH funding in acute myocardial infarction, genomics and stem cell research, 2002-present

• Molecular Biology, Penn State University

• American College of Cardiology, 1985-Present
• American College of Physicians, 1980-Present
• American Association for Advancement of Science,1992-Present
• American Heart Association, Scientific Council on Arteriosclerosis,1995-Present
• American Heart Association, Scientific Council on Clinical Cardiology,1995-Present

• Abnormal Stress Test
• Angiogenesis
• Angiography
• Angioplasty
• Aorta Surgery
• Atherectomy
• Bifurcation Blockage
• Cardiac Catheterization
• Carotid Angiography
• Clinical Trials
• Coronary Artery Atherectomy
• Coronary Balloon Angioplasty (PTCA)
• Enhanced External Counterpulsation (EECP)
• Exercise Stress Test
• FFR determination
• Interpretation of Genetic Risk Factors: Coronary Artery Disease
• Mitral Valve Repair
• Optical Coherence Tomography
• Percutaneous Valve Treatment
• Rotational Atherectomy
• Stem Cell Therapy For Heart Disease
• Stress Testing
• Total Coronary Occlusions
• Virtual Histology

• Angina
• Atherosclerosis (vascular)
• Coronary Aneurysm
• Heart Attack
• Restenosis

Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical education about recent trends. The collaborations are reviewed as part of the Cleveland Clinic’s procedures. The Cleveland Clinic publicly discloses payments to its physicians and scientists for speaking and consulting of $5,000 or more per year, and any equity, royalties, and fiduciary relationships in companies with which they collaborate. In publicly disclosing this information, the Cleveland Clinic tries to provide information as accurately as possible about its doctors’ connections with industry and those of their immediate family members. As of 7/30/2008, Dr. Ellis has reported the financial relationships with the companies listed below. Patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by the Cleveland Clinic. To learn more about the Cleveland Clinic’s policies on collaborations with industry and innovation management, go to our Integrity in Innovation page.

Consulting. Dr. Ellis receives fees of $5,000 or more per year as a paid consultant or speaker for the following companies:

BioHeart Inc.

Boston Scientific Corporation

Cordis Corporation

Viacor, Inc.

Abbott Vascular

• English